Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

CoROM cast. Wilderness, Austere, Remote and Resource-limited Medicine.

134-Malaria Deep Dive with Jason Jarvis

14 Mar 2025

Description

This week, Jason Jarvis joins Aebhric O’Kelly on a deep dive into malaria, covering the lifecycle, symptoms, diagnostic tools, treatment options, and the latest vaccine developments. The discussion emphasises the importance of understanding malaria's complexities, the challenges in diagnosis and treatment, and the promising advancements in vaccine research to eradicate this deadly disease.TakeawaysParasitic protozoa transmitted by Anopheles mosquitoes cause malaria.The lifecycle of malaria involves complex stages in both mosquitoes and humans.Symptoms of malaria can vary significantly based on previous exposure to the disease.Severe malaria can lead to critical conditions like altered consciousness and hypoglycaemia.Rapid diagnostic tests (RDTs) are essential but not foolproof in detecting malaria.The R21 malaria vaccine shows promising efficacy and significantly advances malaria prevention.Public health efforts primarily focus on protecting vulnerable populations, especially children.Understanding the fever patterns can aid in diagnosing malaria and other diseases.Vaccination for adults is being researched, but current recommendations prioritise children.Staying informed through reputable sources like WHO and CDC is crucial for those travelling to malaria-endemic areas.Chapters00:00 Introduction to Malaria and Its Lifecycle14:58 Understanding Malaria Symptoms and Severity30:07 Diagnostic Tools and Treatment Options34:09 Vaccines: Current Developments and Future Prospects44:57 Resources for Further Learning

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.